Proteon Therapeutics, Inc. Gains 30.5%
Wed 15 Jan 20 at 05:30 PM
Proteon Therapeutics, Inc. (PRTO:NASDAQ) shot up at $0.84, representing a gain of 30.5%. The stock appeared on our News Catalysts scanner on Thu 09 Jan 20 at 07:00 PM in the 'MERGER' category. From Mon 23 Dec 19, the stock recorded 64.29% Up Days and 80.00% Green Days
About Proteon Therapeutics, Inc. (PRTO:NASDAQ)
Proteon Therapeutics Inc is an late-stage biopharmaceutical company engaged in the development of novel pharmaceuticals to address the needs of patients with renal and vascular disease.
Top 10 Gainers:
- Reebonz Holding Limited (RBZ:NASDAQ), 67.27%
- Cemtrex, Inc. (CETX:NASDAQ), 54.24%
- OrganiGram Holdings Inc. (OGI:NASDAQ), 45.37%
- The Peck Company Holdings, Inc. (PECK:NASDAQ), 44.12%
- Fluent, Inc. (FLNT:NASDAQ), 40.64%
- Pope Resources, A Delaware Limited Partnership (POPE:NASDAQ), 35.49%
- Allied Esports Entertainment Inc. (AESE:NASDAQ), 32.4%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- Ra Medical Systems, Inc. (RMED:NYSE), 29.3%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 28.87%